MDS-171: Effects of Luspatercept on Serum Ferritin in Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) with Ring Sideroblasts (RS) in the Phase 3 MEDALIST Trial

Autor: Fenaux, Pierre, Santini, Valeria, Mufti, Ghulam J., Diez-Campelo, María, Finelli, Carlo, Sekeres, Mikkael A., Quesnel, Bruno, Beyne-Rauzy, Odile, Garcia-Manero, Guillermo, Komrokji, Rami S., Buckstein, Rena, Voso, Maria Teresa, Selleslag, Dominik, DeZern, Amy E., Greenberg, Peter L., Zeidan, Amer M., Adès, Lionel, Verma, Amit, Savona, Michael R., Laadem, Abderrahmane, Ito, Rodrigo, Zhang, Jennie, Rampersad, Anita, Sinsimer, Daniel, Morison, Jessica, Louis, Chrystal, Linde, Peter G., Platzbecker, Uwe
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2020 20 Supplement 1:S317-S317
Databáze: ScienceDirect
Externí odkaz: